Author:
Borgeat Pierre,Picard Serge,Dallaire Nancy,Pouliot Marc,Surette Marc E.
Reference51 articles.
1. Borgeat, P. and Naccache, P. H. (1990) Biosynthesis and biological activity of leukotriene B4. Clin. Biochem. 23, 459–468.
2. Serhan, C. N. and Drazen, J. M. (1997) Antiinflammatory potential of lipoxygenase-derived eicosanoids: a molecular switch at 5 and 15 positions? J. Clin. Invest. 99, 1147,1148.
3. Venable, M. E., Zimmerman, G. A., Mcintyre, T. M., and Prescott, S. M. (1993) Review—platelet-activating factor—a phospholipid autacoid with diverse actions. J. Lipid Res. 34, 691–702.
4. Griffiths, R. J., Pettipher, E. R., Koch, K., Farrell, C. A., Breslow, R., Conklyn, M. J., Smith, M. A., Hackman, B. C., Wimberly, D. J., Milici, A. J., Scampoli, D. N., Cheng, J. B., Pillar, J. S., Pazoles, C. J., Doherty, N. S., Melvin, L. S., Reiter, L. A., Biggars, M. S., Falkner, F. C., Mitchell, D. Y., Liston, T. E., and Showell, H. J. (1995) Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc. Natl Acad. Sci. USA 92, 517–521.
5. Hay, D. W. P., Torphy, T. J., and Undem, B. J. (1995) Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol Sci. 16, 304–309.